SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013245
Filing Date
2023-08-03
Accepted
2023-08-03 16:21:30
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20230630x10q.htm   iXBRL 10-Q 1813814
2 EX-31.1 ptgx-20230630xex31d1.htm EX-31.1 10156
3 EX-31.2 ptgx-20230630xex31d2.htm EX-31.2 10146
4 EX-32.1 ptgx-20230630xex32d1.htm EX-32.1 10119
5 GRAPHIC ptgx-20230630x10q007.jpg GRAPHIC 102172
  Complete submission text file 0001558370-23-013245.txt   7253744

Data Files

Seq Description Document Type Size
6 EX-101.SCH ptgx-20230630.xsd EX-101.SCH 43821
7 EX-101.CAL ptgx-20230630_cal.xml EX-101.CAL 47932
8 EX-101.DEF ptgx-20230630_def.xml EX-101.DEF 177853
9 EX-101.LAB ptgx-20230630_lab.xml EX-101.LAB 367063
10 EX-101.PRE ptgx-20230630_pre.xml EX-101.PRE 308478
55 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20230630x10q_htm.xml XML 1286587
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 231140395
SIC: 2834 Pharmaceutical Preparations